Breda, Netherlands

Argen-x N.v.


USPTO Granted Patents = 11


Trademarks = 1

Forward Citations = 76

Loading Chart...
Loading Chart...

22 inventors (with patents filed for the assignee):

goldMedal Torsten Dreier (9 out of 27 patents)

silverMedal Natalie De Jonge (6 out of 10 patents)

bronzeMedal Johannes Joseph Wilhelmus De Haard (6 out of 34 patents)

4 Anna Hultberg (5 out of 8 patents)

5 Johannes De Haard (5 out of 11 patents)

6 Michael Saunders (4 out of 13 patents)

7 Els Festjens (4 out of 6 patents)

8 Karen Silence (3 out of 22 patents)

9 Peter Ulrichts (3 out of 10 patents)

10 Christophe Blanchetot (2 out of 22 patents)

11 Paolo Michieli (2 out of 12 patents)

12 Michael John Scott Saunders (2 out of 24 patents)

13 Harald Wajant (2 out of 5 patents)

14 Sofie Maria Elvire Gabriels (2 out of 5 patents)

15 Mahan Moshir (2 out of 7 patents)


11 patents:

ARGEN-X N.V. is a global biotechnology company focused on creating and developing differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer. They utilize the power of their proprietary SIMPLE Antibody™ platform to discover and develop antibodies, including their lead product candidate efgartigimod, which targets several autoimmune diseases. With a mission to improve the lives of patients, ARGEN-X N.V. is dedicated to delivering innovative therapies that address unmet medical needs. For more information, visit their website.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

11 Patents

#7 in Breda

#563 in Netherlands

#50,159 in the World

...
Breda, Netherlands
Forward Citations = 76

22 inventors:

Please report any incorrect information to support@idiyas.com
Loading…